UCI bans Bardiani CSF for 30 days after Giro d'Italia doping scandal
The Pro Continental team have been banned for 30 days after two riders tested positive for growth hormones at the Giro d'Italia earlier this year
A UCI ruling has suspended Bardiani CSF for 30 days after the governing body concluded its investigation into two riders from the team who tested positive for growth hormones earlier this year.
In accordance with rule 7.21.1, if two riders on a team are caught utilising banned substances the team will subsequently be banned for 15 to 45 days, meaning this isn't the harshest sentence they could've received but nor is it a slap on the wrist.
Bardiani CSF will be banned from racing for the next 30 days forcing them to miss the Tour of Austria which they had hoped to have contended for next month (July 2-9). However, the ban is limited to international races meaning that Bardiani riders can take place in the Italian National Road Race Championships on 24th and 25th June.
The pair, Nicola Ruffoni and Stefano Pirazzi, had tested positive for GH-Releasing Peptides (GHRPs) on the eve of the 2017 Giro d'Italia but had relied on their B samples to prove their innocence. Their hope was soon vanquished when it was revealed their B samples tested positive too and they were to be sacked from their team.
The UCI ban starts tomorrow keeping the team out of international races until the 14th July before they take on the Tour of Utah at the end of the month.
Get The Leadout Newsletter
The latest race content, interviews, features, reviews and expert buying guides, direct to your inbox!
Thank you for reading 20 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
-
Bike insurance might not cover your theft: How to avoid the common mistakes that can invalidate your policy
Having your bike stolen is bad enough, don't let a failed insurance claim make it worse
By Rob Kemp Published
-
Stock but not standard: Argonaut Cycles upgrades its stock offering to flagship status; launches carbon gravel wheels
With 13 frame geometries, Argonaut’s high-end stock program aims to streamline the buying process of its handmade bikes
By Anne-Marije Rook Published
-
UK team asking athletes to pay £500 for a 'performance test review' as part of application and has insisted riders sign an NDA to join
British Continental team Saint Piran charging hefty fee for data review with no guarantee that applicants will get a place on the team
By Tom Thewlis Published
-
Irish Continental level professional cyclist suspended after EPO positive
Jesse Ewart, who rode for Terengganu Cycling, has been banned until 2027
By Adam Becket Published
-
What is the new 'yellow card' system in place at the Tour de France Femmes?
Barbara Guarischi becomes first rider to receive booking after yellow card trial brought in by world governing body
By Tom Thewlis Published
-
'We are not afraid': UCI to pay for 'qualified information' relating to possible motor doping
President David Lappartient also says that he is "not afraid to to catch a top rider" should they be using motored assistance inside their bike
By Chris Marshall-Bell Published
-
Yellow cards to be trialled in pro cycling amid raft of UCI rule changes
The way time gaps are calculated is also set to be altered
By Adam Becket Published
-
'All the conditions are met, then it's questioned again' - Visma-Lease a Bike bemoan UCI review after 'a lot of money' spent on development of Giro helmet
Team reacts to governing body statement on Tuesday, day after new helmet was debuted
By Tom Thewlis Published
-
The UCI is banning time trial helmet optimisations - one day after Giro lid broke cover
The 'head sock' is out, with more helmets to be reviewed - whilst hookless rim investigation is still ongoing
By Adam Becket Published
-
Convicted EPO doper Jarlinson Pantano returns to cycling with Colombian EPM team
Former Trek-Segafredo and IAM Cycling rider rejoins peloton after his four-year band expires
By Adam Becket Published